You are here

albuminuria

Boehringer Ingelheim and Lilly initiate MARLINA clinical trial to evaluate use of Tradjenta® (linagliptin) tablets in patients with type 2 diabetes and albuminuria

Yahoo

Tue, 03/19/13 - 10:43 am

Boehringer Ingelheim